Literature DB >> 8404104

Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases.

Y Kondoh1, H Taniguchi, Y Kawabata, T Yokoi, K Suzuki, K Takagi.   

Abstract

We treated three patients with idiopathic pulmonary fibrosis who had an acute clinical exacerbation. We analyzed their clinical, radiographic, therapeutic, and pathologic findings. Their initial symptoms were influenza-like illness or cough with fever, and all had leukocytosis and elevation of C-reactive protein. Infectious events were ruled out by extensive bacteriologic and serologic examination. The patients' lung injury scores progressed rapidly to severe lung injury compatible with adult respiratory distress syndrome. Findings from bronchoalveolar lavage fluid showed marked neutrophilia and elevation of albumin concentrations. All patients showed various degrees of improvement following corticosteroid therapy. Histologic findings from open lung biopsy specimens showed both usual interstitial pneumonia (UIP) and organizing acute lung injury pattern. Whether these two forms of interstitial pneumonia (UIP and acute lung injury pattern) are variants of one disease or are unrelated and also the effectiveness of corticosteroid therapy on such conditions remain to be determined by further studies.

Entities:  

Mesh:

Year:  1993        PMID: 8404104     DOI: 10.1378/chest.103.6.1808

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  94 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-2002. A 56-year-old man with rapidly worsening dyspnea.

Authors:  Michelle Ng Gong; Eugene J Mark
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

2.  Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Carolyn S Calfee; Paul J Wolters; Jin Woo Song; Sang-Bum Hong; Sandra Brady; Akitoshi Ishizaka; Kirk D Jones; Talmadge E King; Michael A Matthay; Dong Soon Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-23       Impact factor: 5.464

Review 3.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

Review 4.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

Review 5.  Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

Authors:  Gary W Hunninghake; Marvin I Schwarz
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

Review 6.  Reactive oxygen species as signaling molecules in the development of lung fibrosis.

Authors:  Francisco J Gonzalez-Gonzalez; Navdeep S Chandel; Manu Jain; G R Scott Budinger
Journal:  Transl Res       Date:  2017-10-10       Impact factor: 7.012

7.  Activation of heat shock response augments fibroblast growth factor-1 expression in wounded lung epithelium.

Authors:  Rachel G Scheraga; Christopher Thompson; Mohan E Tulapurkar; Ashish C Nagarsekar; Mark Cowan; Ratnakar Potla; Junfeng Sun; Rongman Cai; Carolea Logun; James Shelhamer; Nevins W Todd; Ishwar S Singh; Irina G Luzina; Sergei P Atamas; Jeffrey D Hasday
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-16       Impact factor: 5.464

8.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

9.  Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality.

Authors:  Kiminori Fujimoto; Hiroyuki Taniguchi; Takeshi Johkoh; Yasuhiro Kondoh; Kazuya Ichikado; Hiromitsu Sumikawa; Takashi Ogura; Kensuke Kataoka; Takahiro Endo; Atsushi Kawaguchi; Nestor L Müller
Journal:  Eur Radiol       Date:  2011-08-07       Impact factor: 5.315

10.  Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.

Authors:  Andreina Manfredi; Marco Sebastiani; Stefania Cerri; Caterina Vacchi; Roberto Tonelli; Giovanni Della Casa; Giulia Cassone; Amelia Spinella; Pancaldi Fabrizio; Fabrizio Luppi; Carlo Salvarani
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.